- Novo Nordisk signed a deal to acquire Irish biotech Prothena’s experimental anti-amyloid heart drug and broader amyloidosis program.
- Eli Lilly acquired Protomer Technologies, a biotech that engineers peptides and proteins.
- GlaxoSmithKline signed a deal with iTeos Therapeutics to co-develop and co-commercialize its experimental monoclonal antibody cancer treatment.
- Merck signed a deal with the U.S. government under which it will receive $1.2 billion for 1.7 million courses of its COVID-19 antiviral drug molnupiravir if it’s FDA-authorized.
- Walgreens sold its wholesaling arm, Alliance Healthcare, to AmerisourceBergen for $6.5 billion.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
